Virus and radiation combo takes aim at tough sarcomas
NCT ID NCT06660810
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether injecting a modified herpes virus (TVEC) directly into tumors, combined with radiation therapy before surgery, can shrink advanced soft tissue sarcomas. The study enrolled 2 adults with specific sarcoma types that could not be removed with clear margins. The main goal is to see if at least 90% of the tumor dies from the treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Talimogene laherparepvec (TVEC), a modified herpes virus that attacks cancer cells
- What this could lead to
- If it works, this combination could shrink sarcomas enough to allow successful surgery, potentially improving survival and reducing recurrence.
- What could go wrong
- This is a very early, tiny trial (only 2 participants) with no control group. The virus may cause flu-like symptoms or injection site reactions, and the approach may not work for all sarcoma types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa
Iowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a Tumor-Injected drug combo outlast standard care in advanced sarcoma?
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a targeted pill stall advanced sarcomas?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells